Damon Runyon Clinical Investigator Award

Posted in Announcement  |  Tagged ,

Limited Submission

Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine by providing them with the resources and training structure essential to becoming successful clinical investigators.


$600,000 over three years


  • Internal Deadline: January 3, 2020
  • Sponsor Deadline (if nominated): February 3, 2020


  • Apply within the first five (5) years of their initial full faculty appointment (Cut-off date: July 1, 2015).
  • Hold an independent assistant professor position or equivalent.
  • Have received an MD, DO, or MD/PhD degree(s) from an accredited institution, completed their subspecialty training and be U.S. Board eligible, and hold a valid, active U.S. medical license at the time of application.
  • Be a U.S. citizen or permanent legal resident.
  • Cannot hold an R01 at the time of application.
  • Commit to spending 80% of their time conducting research.
  • Apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award. 
    • No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time.

Selection Criteria

Address these to be competitive.

  • Excellence of the applicant and Mentor.
  • Innovation, creativity, quality and originality of the research proposal.
  • The commitment of the Mentor and institution to the development and training of the applicant as a skilled clinical research investigator.
  • Evidence of the applicant’s commitment to clinical translational and/or cancer prevention research and their ability to apply advances in laboratory research to clinical problems.
  • Importance of the proposed research to the field of cancer and/or cancer prevention.
  • Adherence of the proposal to the definition of clinical research as set out in guidelines.
  • Adherence to the “Handshake Rule.”

Submission Information

Send the following as a single PDF document to Jennifer Kluge at jck67@georgetown.edu (new window)

  1. 1-page research proposal with a rationale for why you should be nominated and how your proposed research advances your long-term vision and goals in the field of clinical cancer investigation. You should outline your historical, current, and future commitments to clinical/patient research and should consider the aforementioned “Selection Criteria to be Competitive”.
  2. Abbreviated CV or NIH-style biosketch

Additional Details

Go to the Damon Runyon website for more additional guidelines.

For further questions about the sponsor, contact George Kosar, Assistant Vice President, Office of Institutional Partnerships at George.kosar@georgetown.edu (new window).